Discovery of 1,2,3,4-tetrahydrocarbazo-1yl-acetic acids as fatty acid binding protein 4/5 (FABP4/5) inhibitors

被引：0

作者：

Lin, Songnian ^{[1
]}

Deng, Qiaolin ^{[1
]}

Yang, Lihu ^{[1
]}

Chapman, Kevin ^{[1
]}

Wei, Changqing ^{[2
]}

Zhang, Fuzhi ^{[2
]}

Jiao, Zhigang ^{[2
]}

Song, Ji ^{[2
]}

Li, Jinyuan ^{[2
]}

Wu, Hao ^{[2
]}

Qureshi, Sajjad A. ^{[1
]}

Berger, Joel P. ^{[1
]}

Becker, Joe ^{[1
]}

Fitzgerald, Paula ^{[1
]}

Salituro, Gino ^{[1
]}

Sharma, Nandani ^{[1
]}

Xu, Serena ^{[1
]}

Yang, Ruojing ^{[1
]}

Yang, Xiaodong ^{[1
]}

Zhang, Bei B. ^{[1
]}

机构：

[1] Merck Res Labs, Dept Discovery & Preclin Sci, Rahway, NJ 07065 USA

[2] WuXi AppTec, Dept Med Chem, Shanghai 200131, Peoples R China

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 244卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

121-MEDI

引用

页数：1

共 50 条

[41] Correction to: Serum fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus
Hui Ning
Hong Tao
Zhanping Weng
Xingbo Zhao
Acta Diabetologica, 2018, 55 : 1089 - 1089
[42] Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma
Thompson, Kyle J.
Austin, Rebecca Garland
Nazari, Shayan S.
Gersin, Keith S.
Iannitti, David A.
McKillop, Iain H.
LIVER INTERNATIONAL, 2018, 38 (06) : 1074 - 1083
[43] Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
Furuhashi, Masato
Saitoh, Shigeyuki
Shimamoto, Kazuaki
Miura, Tetsuji
CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2014, 8 : 23 - 33
[44] Fenofibrate Attenuates Radiation-Induced Oxidative Damage to the Skin through Fatty Acid Binding Protein 4 (FABP4)
Sun, Chuntang
Song, Bin
Sheng, Wenjiong
Yu, Daojiang
Yang, Tingyi
Geng, Fenghao
Fang, Kai
Jiao, Yang
Zhang, Jie
Zhang, Shuyu
FRONTIERS IN BIOSCIENCE-LANDMARK, 2022, 27 (07):
[45] Fatty Acid-Binding Protein 4 (FABP4) Is Associated with Cartilage Thickness in End-Stage Knee Osteoarthritis
Schadler, Paul
Lohberger, Birgit
Thauerer, Bettina
Faschingbauer, Martin
Kullich, Werner
Stradner, Martin Helmut
Husic, Rusmir
Leithner, Andreas
Steinecker-Frohnwieser, Bibiane
CARTILAGE, 2021, 13 (2_SUPPL) : 1165S - 1173S
[46] Expression of the VEGF/VEGFR2 Regulated Fatty Acid Binding Protein 4 (FABP4) in Endothelial Cells of Ovarian Carcinomas and Metastasis
Gwin, K.
Lengyel, E.
Dogan, S.
Buell-Gutbrod, R.
MODERN PATHOLOGY, 2010, 23 : 386A - 387A
[47] Development of FABP4/5 inhibitors with potential therapeutic effect on type 2 Diabetes Mellitus
He, Yu-Long
Chen, Meng-Ting
Wang, Ting
Zhang, Ming-Ming
Li, Ying-Xia
Wang, He-Yao
Ding, Ning
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 224
[48] Correlation between Serum Fatty Acid Binding Protein 4 (FABP4) Levels and Cardiac Function in Patients with Thalassemia Major
Fianza, Pandji I.
Rahmawati, Anita
Afifah, Shofura
Praptama, Suhendra
Ghozali, Mohammad
Sihite, Teddy A.
Setiabudi, Djatnika
Syamsunarno, Mas R. A. A.
Fucharoen, Suthat
Panigoro, Ramdan
DISEASE MARKERS, 2021, 2021
[49] Fatty acid binding protein 4 (FABP4) increases blood pressure via enhancing peripheral arterial resistance in rats
Yamawaki, Hideyuki
Kogane, Taisuke
Kazama, Kyosuke
Okada, Muneyoshi
Hara, Yukio
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 240P - 240P
[50] Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury
Obajdin, Jana
Cotter, Mabel
Snelling, Sara
Dremier, Sarah
De Ron, Pierrette
Fleurance, Renaud
Valentin, Jean-Pierre
da Costa, Andre Nogueira
Gryshkova, Vitalina
TOXICOLOGICAL SCIENCES, 2018, 166 (02) : 441 - 450

← 1 2 3 4 5 →